NCT03352895View on ClinicalTrials.gov

The Effects of Resveratrol on the Complications of Patients With Hemodialysis

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Chronic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

resveratrol

Grape seed extract 100mg Microcrystalline Cellulose 90mg Magnesium Stearate 2mg Gelatin 100mg

DIETARY_SUPPLEMENT

Placebo

The gel contains a mixture of glucose and maltodextrin - a complex carbohydrate - along with fat and a trace of protein.

Trial Locations (1)

66247

Dalin Tzu Chi Hospital, Chiayi City

All Listed Sponsors
lead

Dalin Tzu Chi General Hospital

OTHER

NCT03352895 - The Effects of Resveratrol on the Complications of Patients With Hemodialysis | Biotech Hunter | Biotech Hunter